KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Accumulated Expenses (2018 - 2023)

BioNTech SE's Other Accumulated Expenses history spans 6 years, with the latest figure at $52.6 million for Q3 2023.

  • On a quarterly basis, Other Accumulated Expenses fell 36.33% to $52.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was $52.6 million, a 36.33% decrease, with the full-year FY2020 number at $1.1 million, up 27.22% from a year prior.
  • Other Accumulated Expenses hit $52.6 million in Q3 2023 for BioNTech SE, down from $82.6 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for BNTX hit a ceiling of $82.6 million in Q3 2022 and a floor of $843448.4 in Q4 2019.
  • Historically, Other Accumulated Expenses has averaged $23.5 million across 5 years, with a median of $12.9 million in 2021.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 87.95% in 2019 and later soared 542.42% in 2022.
  • Tracing BNTX's Other Accumulated Expenses over 5 years: stood at $843448.4 in 2019, then increased by 27.22% to $1.1 million in 2020, then soared by 1097.9% to $12.9 million in 2021, then soared by 542.42% to $82.6 million in 2022, then crashed by 36.33% to $52.6 million in 2023.
  • Business Quant data shows Other Accumulated Expenses for BNTX at $52.6 million in Q3 2023, $82.6 million in Q3 2022, and $12.9 million in Q3 2021.